Author

Kan Li

Rutgers, The State University of New JerseyORCID 0000-0002-0825-1934Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Jun WangiD· 2 shared Ahmadullah AnsariiD· 1 shared Alexandra Ford· 1 shared Ashima ChopraiD· 1 shared Bin TaniD· 1 shared Brian R. RoodiD· 1 shared Cheng FengiD· 1 shared Chunchao ZhangiD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Jun WangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologySciencePeer-reviewedMar 28, 2024

Design of SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model

Bin Tan, Xiaoming Zhang, Ahmadullah Ansari…·Jun Wang

The paper designs SARS-CoV-2 PLpro inhibitors that show antiviral efficacy in a mouse model against SARS-CoV-2 and its variants.

140 citationstop 1%

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 19, 2024

CAMKV Kinase Signaling Is a Novel Therapeutic Avenue with Prognostic Relevance in Neuroblastoma

Yang Yu, Yanling Zhao, Zhongcheng Shi…·Jianhua Yang

This study identifies CAMKV kinase signaling as a critical driver of neuroblastoma growth and shows it as a potential therapeutic target and prognostic marker.

DOI 10.1101/2024.02.19.581040

humanproteomics

𝕏 PostBluesky